Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Revelation Biosciences, Inc. - Common Stock (NQ:REVB)

0.4800 -0.0701 (-12.74%)

Streaming Delayed Price Updated: 9:40 AM EST, Jan 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Revelation Biosciences, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

November 04, 2022

We're starting off the final day of trading this week with a look at the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

November 03, 2022

We're starting off the day with a look at the latest news behind the biggest pre-market stock movers for Thursday morning!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

November 01, 2022

Good morning, investor! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!

Via InvestorPlace

Revelation Biosciences Stock Soars After Encouraging Preclinical Data From Kidney Disease Candidate ↗

October 25, 2022

Via Benzinga

Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday ↗

October 27, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 26, 2022

Gainers

Via Benzinga

Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session ↗

October 26, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 26, 2022

Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 47.9% to $0.31 during Wednesday's pre-market session. The company's market cap stands at $11.8 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 26, 2022

It's time to start off the day with a breakdown of the biggest pre-market stock movers for Wednesday morning and the latest news!

Via InvestorPlace

Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday ↗

October 26, 2022

Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 25, 2022

Gainers DBV Technologies (NASDAQ:DBVT) stock increased by 18.7% to $1.9 during Tuesday's after-market session. The company's market cap stands at $356.7 million.

Via Benzinga

Nasdaq Surges Over 200 Points; General Electric Posts Downbeat Earnings ↗

October 25, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 25, 2022

Gainers

Via Benzinga

Revelation Biosciences (REVB) Stock Soars 70% on Positive Pre-Clinical Data ↗

October 25, 2022

Here's what has investors in Revelation Biosciences in a good mood today, as REVB stock surges more than 70%.

Via InvestorPlace

S&P 500 Rises Over 1%; General Motors Earnings Top Views ↗

October 25, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.8% on Tuesday.

Via Benzinga

Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session ↗

October 25, 2022

Gainers

Via Benzinga

Revelation Biosciences Inc. Announces Positive Results in Preclinical Model of Acute and Chronic Kidney Disease

October 25, 2022

From Revelation Biosciences Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 25, 2022

Gainers Taysha Gene Therapies (NASDAQ:TSHA) stock increased by 36.4% to $2.06 during Tuesday's pre-market session. The market value of their outstanding shares is at $84.6 million.

Via Benzinga

Why Morgan Stanley Shares Are Trading Lower, Here Are 43 Stocks Moving In Friday's Mid-Day Session ↗

October 14, 2022

Gainers Intelligent Living Application Group Inc. (NASDAQ: ILAG) surged 77.7% to $9.35.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 14, 2022

Gainers Imara (NASDAQ:IMRA) stock moved upwards by 37.2% to $3.54 during Friday's pre-market session. The market value of their outstanding shares is at $93.0 million.

Via Benzinga

Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday ↗

October 07, 2022

Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.

Via Benzinga

Nasdaq Edges Higher; AngioDynamics Shares Plummet ↗

October 06, 2022

U.S. stocks pared losses midway through trading, with the Nasdaq Composite turning higher on Thursday.

Via Benzinga

Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

October 06, 2022

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...

Via Benzinga

Why Revelation Biosciences Stock Is Popping Off ↗

October 06, 2022

Revelation Biosciences Inc (NASDAQ: REVB) shares are trading higher after the company announced an exclusive worldwide license agreement with Vanderbilt University to develop and commercialize...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 06, 2022

Gainers Statera BioPharma (NASDAQ:STAB) stock increased by 64.8% to $0.23 during Thursday's pre-market session. The company's market cap stands at $11.5 million.

Via Benzinga

Revelation Biosciences Inc. and Vanderbilt University Enter Exclusive Worldwide License Agreement

October 06, 2022

From Revelation Biosciences Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 05, 2022

It's time for another overview of the biggest pre-market stock movers for Wednesday as we cover the news behind share movement this morning!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

September 26, 2022

Good morning, investor! We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

September 22, 2022

It's time for an overview of the biggest pre-market stock movers for Thursday and all the news behind this morning's movement.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 20, 2022

Gainers CinCor Pharma (NASDAQ:CINC) shares moved upwards by 19.5% to $33.0 during Tuesday's after-market session. The market value of their outstanding shares is at $1.4 billion.

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Revelation Biosciences, Inc. - Common Stock (NQ:REVB)

All News about Revelation Biosciences, Inc. - Common Stock